Cargando…
Perfusion reduces bispecific antibody aggregation via mitigating mitochondrial dysfunction-induced glutathione oxidation and ER stress in CHO cells
One major challenge observed for the expression of therapeutic bispecific antibodies (BisAbs) is high product aggregates. Aggregates increase the risk of immune responses in patients and therefore must be removed at the expense of purification yields. BisAbs contain engineered disulfide bonds, which...
Autores principales: | Sinharoy, Pritam, Aziz, Aaron H., Majewska, Natalia I., Ahuja, Sanjeev, Handlogten, Michael W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538420/ https://www.ncbi.nlm.nih.gov/pubmed/33024175 http://dx.doi.org/10.1038/s41598-020-73573-4 |
Ejemplares similares
-
Engineering death resistance in CHO cells for improved perfusion culture
por: MacDonald, Michael A., et al.
Publicado: (2022) -
Characterization of glutathione proteome in CHO cells and its relationship with productivity and cholesterol synthesis
por: Chevallier, Valentine, et al.
Publicado: (2020) -
Chemical chaperone suppresses the antibody aggregation in CHO cell culture
por: Onitsuka, Masayoshi, et al.
Publicado: (2013) -
A novel hydrogen peroxide evolved CHO host can improve the expression of difficult to express bispecific antibodies
por: Mistry, Rajesh K., et al.
Publicado: (2021) -
Vector design for enhancing expression level and assembly of knob-into-hole based FabscFv-Fc bispecific antibodies in CHO cells
por: Ong, Han Kee, et al.
Publicado: (2022)